2015
DOI: 10.1016/j.jhep.2015.03.014
|View full text |Cite
|
Sign up to set email alerts
|

Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
149
1
5

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 156 publications
(167 citation statements)
references
References 38 publications
11
149
1
5
Order By: Relevance
“…Viral eradication in patients with chronic HCV infection has been shown to result in improvements in medium and long term outcomes -assessed both by patient reported quality of life measurements and mortality/morbidity [10][11][12]. However in patients with advanced, decompensated cirrhosis it is uncertain whether treatment and viral clearance is beneficial, and if meaningful functional hepatic recovery is possible.…”
Section: Introductionmentioning
confidence: 99%
“…Viral eradication in patients with chronic HCV infection has been shown to result in improvements in medium and long term outcomes -assessed both by patient reported quality of life measurements and mortality/morbidity [10][11][12]. However in patients with advanced, decompensated cirrhosis it is uncertain whether treatment and viral clearance is beneficial, and if meaningful functional hepatic recovery is possible.…”
Section: Introductionmentioning
confidence: 99%
“…Also Younossi , et al ( 2015) stated current therapies are not yet good enough to eradicate the hepatitis C virus in all treated patients, factors regarding the impact of therapy on quality of life must be entertained and discussed with the patient, prior to embarking on a course of treatment. Antiviral therapies are associated with a decline in quality of life, which returns to baseline when therapy is terminated.…”
Section: Discussionmentioning
confidence: 99%
“…Also, subjects who received the interferon-free regimen experienced substantially less fatigue compared with the subjects HCV and Work Ability Assessment http://dx.doi.org/10.5772/intechopen.70774receiving interferon-containing regimens [22]. Another study by Younossi et al showed that interferon and ribavirin-free regimen are associated with signiicant gains in most aspects of HRQL during treatment regardless of the stage of liver disease [24]. Expanding the access to a highly efective cure for all HCV-infected patients will improve the clinical outcomes but also patient-reported outcomes such as HRQL and work productivity, resulting in a superb comprehensive beneit to patients and society.…”
Section: The Impact Of the Hcv Antiviral Therapy On Work Abilitymentioning
confidence: 99%